Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Hepatitis C virus (HCV) is associated with the development of cirrhosis and hepatocellular carcinoma. We recently found that bovine lactoferrin, a milk protein belonging to the iron transporter family, effectively prevented HCV infection in cultured human hepatocytes (PH5CH8). We tested the hypothesis that lactoferrin inhibits HCV viremia in patients with chronic hepatitis C. Eleven patients with chronic hepatitis C received an 8‐week course of bovine lactoferrin (1.8 or 3.6 g/day). At the end of lactoferrin treatment, a decrease in serum alanine transaminase and HCV RNA concentrations was apparent in 3 (75%) of 4 patients with low pretreatment serum concentrations of HCV RNA. However, 7 patients with high pretreatment concentrations showed no significant changes in these indices. This pilot study suggests that lactoferrin is one potential candidate as an anti‐HCV reagent that may be effective for the treatment of patients with chronic hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500
Harmsen, M. C., Swart, P. J., Bethune, M.-P. D., Pauwels, R., Clercq, E. D., The, T. B., & Meijer, D. K. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.380 · Cited by 379
Superti, F., Ammendolia, M. G., Valenti, P., & Seganti, L. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050049 · Cited by 206
Cited by
The antimicrobial activity of lactoferrin: Current status and perspectives
Orsi, N. (2004) · Biometals · doi:10.1023/b:biom.0000027691.86757.e2 · Cited by 368
Antiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356
“Concerning in vivo studies, following the first pilot study of Tanaka and co-workers [97], a trial was”
ResultLactoferrin research, technology and applications
Wakabayashi, H., Yamauchi, K., & Takase, M. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.013 · Cited by 354
Twenty-five years of research on bovine lactoferrin applications
TOMITA, M., WAKABAYASHI, H., SHIN, K., YAMAUCHI, K., YAESHIMA, T., & IWATSUKI, K. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.021 · Cited by 262
Lactoferrin: a multifunctional glycoprotein.
Vorland, L. H. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01499.x · Cited by 252
Metadata
- Authors
- Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., & Sekihara, H.
- Venue
- Japanese Journal of Cancer Research
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 90
- Issue
- 4
- Pages
- 367-371
- ISSN
- 0910-5050 (ISSN-L)
- OpenAlex
- W2012017557
- Cited by
- 136
- References
- 3
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study. https://app.cochat.ai/papers/10.1111/j.1349-7006.1999.tb00756.x
- The paper
- Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., & Sekihara, H. (1999). Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study. Japanese Journal of Cancer Research. https://doi.org/10.1111/j.1349-7006.1999.tb00756.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.